Effectiveness of fixed-dose ezetimibe+ simvastatin in real-life hypercholesterolaemia treatment: a retrospective observational study in Taiwan
YC Shih, HS Lin - Clinical Lipidology, 2017 - Taylor & Francis
Background: Combining statins with ezetimibe synergistically enhances lipid lowering,
thereby reducing the need to prescribe maximal statin doses to achieve low-density …
thereby reducing the need to prescribe maximal statin doses to achieve low-density …
Effectiveness of fixed-dose ezetimibe+ simvastatin in real-life hypercholesterolaemia treatment: a retrospective observational study in Taiwan
S Yi-Chung, L Huan-Sheng - Clinical Lipidology and …, 2017 - search.proquest.com
Background: Combining statins with ezetimibe synergistically enhances lipid lowering,
thereby reducing the need to prescribe maximal statin doses to achieve low-density …
thereby reducing the need to prescribe maximal statin doses to achieve low-density …
Begin with the Real-world Patients of Non-goal-achieved Hypercholesterolemia in Taiwan through the Ezetimibe/Simvastatin Tablet–the BRAVO study
JC Huang, TY Lee, MJ Liou, CM Lin, D Pei… - … medical research and …, 2011 - Taylor & Francis
Objective: To assess the efficacy, safety, and tolerability of a combination of 10 mg ezetimibe
and 20 mg simvastatin in Taiwanese patients with hypercholesterolemia. Research design …
and 20 mg simvastatin in Taiwanese patients with hypercholesterolemia. Research design …
[HTML][HTML] Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open …
Background Reducing low-density lipoprotein cholesterol (LDL-C) is associated with
reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of …
reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of …
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease …
L Ose, A Shah, MJ Davies, J Rotonda… - … medical research and …, 2006 - Taylor & Francis
Background: The combination tablet containing ezetimibe and simvastatin (EZE/SIMVA),
inhibits both the intestinal absorption and endogenous production of cholesterol, providing …
inhibits both the intestinal absorption and endogenous production of cholesterol, providing …
Long-term safety and, tolerability profiles andlipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: A multicenter, randomized …
L Masana, P Mata, C Gagné, W Sirah, M Cho… - Clinical …, 2005 - Elsevier
BACKGROUND:: Ezetimibe (EZE) is a cholesterol-loweringdrug that inhibits absorption of
dietary and biliary cholesterol across the intestinal wall without affecting absorption of bile …
dietary and biliary cholesterol across the intestinal wall without affecting absorption of bile …
Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on …
S Bissonnette, R Habib, F Sampalis, S Boukas… - Canadian Journal of …, 2006 - Elsevier
Background For patients who have above-target low-density lipoprotein cholesterol (LDL-C)
levels while on statin monotherapy, coadministration of a cholesterol absorption inhibitor …
levels while on statin monotherapy, coadministration of a cholesterol absorption inhibitor …
Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients
M Averna, A Zaninelli, C Le Grazie… - Journal of Clinical …, 2010 - Elsevier
BACKGROUND: Reducing low-density lipoprotein cholesterol (LDL-C) is the primary goal of
therapy in patients with hypercholesterolemia and coronary heart disease (CHD) …
therapy in patients with hypercholesterolemia and coronary heart disease (CHD) …
Efficacy of ezetimibe/simvastatin (10/10 mg) versus high dose statin in dyslipidemia patients: a meta-analysis of randomized controlled trials.
YGM Yang GaoMing, HDF Han DengFeng… - 2019 - cabidigitallibrary.org
Background: The monotherapies of statin and ezetimibe had not successfully achieved their
objectives in the management of lipid levels of dyslipidemia patients. We aimed to compare …
objectives in the management of lipid levels of dyslipidemia patients. We aimed to compare …
Ezetimibe coadministered with statin therapy significantly reduces LDL-C and improves goal attainment in patients with hypercholesterolemia
T Pearson, M Denke, P McBride, WP Battisti… - Southern Medical …, 2004 - go.gale.com
Ezetimibe (EZE), coadministered with a statin, offers a dual mechanism for lowering LDL-C.
In this randomized community-based clinical trial, we examined the effectiveness and safety …
In this randomized community-based clinical trial, we examined the effectiveness and safety …